GRAIL, Inc.
GRAL- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001699031
In the last 90 days, GRAIL, Inc. insiders filed 0 open-market purchases and 4 sales; 375 institutions reported holding it in 13F filings for Q2 2026, worth $2.60B in total; no superinvestor holds it.
Superinvestors holding GRAL, Q2 2026
No superinvestor reported holding GRAL in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of GRAL each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q3 2024
0 superinvestors holding at quarter end
- Sold out
- Soros Fund Management
Q2 2024
1 superinvestor holding at quarter end